Loading…
VTRS
Viatris Inc
NASDAQ· Healthcare· Drug Manufacturers - Specialty & Generic· CUSIP 92556V106
$18.48+0.16%Price as of Oct 23, 00:46 UTC · updated once a day, after the close
At a glance
Viatris Inc (VTRS) is listed on NASDAQ and classified in Drug Manufacturers - Specialty & Generic, part of the Healthcare sector. It is headquartered in Canonsburg, United States and has 30,000 employees. The company is worth $21.23B. Revenue was $14.3B in fiscal 2025, down 3.0% from the year before. It reported a net loss of $3.51B. The share price is within 3% of its 52-week high. It pays a dividend yielding 2.60%. 6 of the 38 superinvestors we track held it at the end of Q2 2026. The largest position belongs to Cliff Asness (AQR Capital Management), at $74.56M. In that quarter, 1 of them opened or added to the position and 4 reduced it. No open-market insider trades in it were filed over the last 30 days.
Written from the data on this page: SEC filings (13F, Form 4, annual reports) and market prices.
Key metrics
- Market cap
- $21.23B
- P/E
- —
- Forward P/E
- 6.9x
- P/B
- 1.5x
- Dividend yield
- 2.60%
- Payout
- —
- EPS
- -$0.36
- ROE
- -2.75%
- Profit margin
- -2.79%
- Revenue growth
- +4.90%
- Beta
- 0.86
- 52-week high
- $18.75
- 52-week low
- $9.92
History
Year by year, from the annual reports; dividends from the payments themselves.
Bars are year-end balances; lines are what happened during the year.
Investors holding this
Major managers that reported this stock in their latest 13F.
Price over time
▲ +51.5% over 5Y.
today you would have $1,724.45▲ +72.4%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
Indicators, year by year
The last 8 closed years, each at that year’s closing price and reported numbers.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Year-end price | $12.45 | $12.45 | $10.83 | $11.13 | $13.53 | $18.74 | $20.10 | $27.40 | |
| P/E | — | — | — | 216.6x | 6.5x | — | — | 670.0x | 40.3x |
| P/S | 1.0x | 1.0x | 1.0x | 0.8x | 0.8x | 0.9x | 1.9x |
Fair price, seven ways
Seven formulas applied to the reported numbers, each with its assumption next to the result. None of them predicts a price.
Earnings
—
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
Earnings
—
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
Earnings
—
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
Earnings
—
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
Cash flow
$16.22
Cash flow growing 5.0% a year for 10 years, discounted at 10%, then 2.5% forever.
Operating
—
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
Dividends
Others in the same sector
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| INSMINSMED Inc | $95.06 | — | 27.4x | 0.00% | -87.22% | $20.76B |
| THCTenet Healthcare Corp | $270.63 | 10.5x | 4.7x | 0.00% | 37.34% | $21.79B |
| GHGuardant Health, Inc. | $162.94 | — | — | 0.00% | — | $21.87B |
| BNTXBioNTech SE | $89.67 |
About the company
- 30,000
- Canonsburg, United States
